PlainRecalls
FDA Drug Low Class III Terminated

Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02

Reported: November 13, 2019 Initiated: November 1, 2019 #D-0304-2020

Product Description

Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02

Reason for Recall

Presence of Foreign substance: identified as a dead ant.

Details

Units Affected
28,254 bottles
Distribution
Product was distributed to major distributors/wholesalers throughout the United States.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02. Recalled by Lupin Pharmaceuticals Inc.. Units affected: 28,254 bottles.
Why was this product recalled?
Presence of Foreign substance: identified as a dead ant.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2019. Severity: Low. Recall number: D-0304-2020.